Our scientists take risks
Curiosity is our biggest asset. The freedom to explore leads to new discoveries.
Play
Play
Meet our scientists: Theodora Hatziioannou
“Last summer, the FDA approved lenacapavir as a twice-yearly injection as a means for preventing HIV-1 infection. The WHO recommended it as a preventative soon after. It’s been very, very satisfying to see that our work can be so useful.”
Read more:
Read more:
Meet our scientists: Nathaniel Heintz
"The disorders I'm most interested in involve changes in brain function that regulate either maladaptive human behaviors or late onset neurodeenerative disease."
Watch the video:
Watch the video:
Meet our scientists: Charles M. Rice
“For the first time, we have a system in which natural chronic viral infection drives liver cancer in an immunologically healthy animal, opening the door to studies and preclinical trials that simply weren’t possible before.”
Read more:
Read more:
Meet our scientists: Elaine Fuchs
"The findings could provide valuable inroads for developing new therapeutic strategies for chronic inflammation."
Read more:
Read more:
Get our newsletter
The latest science discoveries delivered monthly to your inbox.